RICERCA
AUTORI
RIVISTE
Sfoglia per AUTORE
SCAGLIOTTI GV
Collezione AOU San Luigi di Orbassano
Items : 175
Role of radium-223 discontinuation due to adverse events in castration-resistant prostate cancer patients. A retrospective monocentric analysis. in Tumori / Tumori. 2023 Apr;109(2):233-243. doi: 10.1177/03008916221077144. Epub 2022 Mar 31.
2023
ASL Asti
ASL Torino 4
AO Ordine Mauriziano
AOU San Luigi di Orbassano
Buttigliero C; Di Maio M; Scagliotti GV; Audisio A; Audisio M; Parlagreco E; Ungaro A; Samuelly A; Pisano C; Urban S; Di Stefano RF; Angusti T; Parente A; Turco F; Tucci M;
Clinical-Molecular Prospective Cohort Study in Non-Small Cell Lung Cancer (PROMOLE study): A Comprehensive Approach to Identify New Predictive Markers of Pharmacological Response. in Clinical lung cancer / Clin Lung Cancer. 2022 May 11:S1525-7304(22)00100-0. doi: 10.1016/j.cllc.2022.05.007.
2022
ASL Torino 4
AOU San Luigi di Orbassano
Pirri F; Bussolino F; Candeloro S; Manganaro L; Righi L; Novello S; Primo L; Bironzo P; Scagliotti GV;
International Association for the Study of Lung Cancer Study of the Impact of Coronavirus Disease 2019 on International Lung Cancer Clinical Trials. in Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer / J Thorac Oncol. 2022 May;17(5):651-660. doi: 10.1016/j.jtho.2022.01.017. Epub 2022 Feb 17.
2022
ASL Torino 4
AOU San Luigi di Orbassano
Barrios CH; Barlesi F; Eralp Y; Johnson ML; Ujhazy P; Kelly KL; Pruett CD; Clark RC; Arndt R; Roy UB; Scagliotti GV; Wakelee HA; Mitsudomi T; Smeltzer MP; Hirsch FR; Bunn PA;
Optimizing the clinical management of EGFR-mutant advanced non-small cell lung cancer: a literature review. in Translational lung cancer research / Transl Lung Cancer Res. 2022 May;11(5):935-949. doi: 10.21037/tlcr-22-1.
2022
ASL Torino 4
AOU San Luigi di Orbassano
Garbo E; Listì A; Bertaglia V; Bironzo P; Passiglia F; Scagliotti GV;
COVID-19 and Lung Cancer: A Comprehensive Overview from Outbreak to Recovery. in Biomedicines / Biomedicines. 2022 Mar 26;10(4):776. doi: 10.3390/biomedicines10040776.
2022
ASL Torino 4
AOU San Luigi di Orbassano
Scagliotti GV; Passiglia F; Bungaro M;
Malignant pleural mesothelioma: Germline variants in DNA repair genes may steer tailored treatment. in European journal of cancer (Oxford, England : 1990) / Eur J Cancer. 2022 Mar;163:44-54. doi: 10.1016/j.ejca.2021.12.023. Epub 2022 Jan 13.
2022
ASL Torino 4
ASL VCO
AOU Città della Salute di Torino
AOU San Luigi di Orbassano
ASL Alessandria
AO Alessandria
AOU Novara
Dianzani I; Matullo G; Magnani C; Ferrante D; Moro L; Migliore E; Mirabelli D; Scagliotti GV; Papotti M; Giachino D; Baietto G; Parini S; Boldorini R; Muzio A; Rena O; Grosso F; Libener R; Allione A; Clavenna MG; Casalone E; Pinton G; Aspesi A; Sculco M; La Vecchia M;
New emerging targets in advanced urothelial carcinoma: Is it the primetime for personalized medicine? in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2022 Jun;174:103682. doi: 10.1016/j.critrevonc.2022.103682. Epub 2022 Apr 11
2022
ASL Asti
ASL Torino 4
ASL Cuneo 1
ASL Cuneo 2
AO Ordine Mauriziano
AOU San Luigi di Orbassano
Buttigliero C; Scagliotti GV; Audisio A; Ortega C; Parlagreco E; Ungaro A; Di Maio M; Di Prima L; Turco F; Audisio M; Di Stefano RF; Tucci M;
Antibody-Drug Conjugates in Urothelial Carcinoma: A New Therapeutic Opportunity Moves from Bench to Bedside. in Cells / Cells. 2022 Feb 25;11(5):803. doi: 10.3390/cells11050803.
2022
ASL Asti
ASL Torino 4
AO Ordine Mauriziano
AOU San Luigi di Orbassano
Buttigliero C; Scagliotti GV; Ungaro A; Di Maio M; Turco F; Audisio A; Delcuratolo MD; Pisano C; Di Prima L; Tucci M;
SKP2 drives the sensitivity to neddylation inhibitors and cisplatin in malignant pleural mesothelioma. in Journal of experimental & clinical cancer research : CR / J Exp Clin Cancer Res. 2022 Feb 23;41(1):75. doi: 10.1186/s13046-022-02284-7.
2022
AOU Città della Salute di Torino
ASL Torino 4
AOU San Luigi di Orbassano
Papotti MG; Righi L; Bussolino F; Taulli R; Gazzano E; Leo F; Grosso F; Comunanza V; Libener R; Facolmatà C; Sandri A; Napoli F; Fontana S; Digiovanni S; Ricci L; Ananthanarayanan P; Bironzo P; Belisario DC; Salaroglio IC; Novello S; Scagliotti GV; Riganti C; Kopecka J;
Impact of the Coronavirus Disease 2019 Pandemic on Global Lung Cancer Clinical Trials: Why It Matters to People With Lung Cancer. in JTO clinical and research reports / JTO Clin Res Rep. 2022 Feb;3(2):100269. doi: 10.1016/j.jtocrr.2021.100269. Epub 2021 Dec 23.
2022
ASL Torino 4
AOU San Luigi di Orbassano
Hirsch FR; Arndt R; Clark RC; Mitsudomi T; Wakelee HA; Scagliotti GV; Norris Xx K; Manley E Jr; Fox J; Ciupek A; Basu Roy U; Baird AM; Bunn PA; Smeltzer MP;
Prognostic factors in metastatic castration resistant prostate cancer patients treated with radium-223: a retrospective study. in Minerva urology and nephrology / Minerva Urol Nephrol. 2022 Dec;74(6):703-713. doi: 10.23736/S2724-6051.22.04701-2. Epub 2022 Feb 11.
2022
ASL Asti
ASL Torino 4
AO Ordine Mauriziano
AOU San Luigi di Orbassano
Buttigliero C; Pisano C; Scagliotti GV; Tucci M; DI Maio M; Samuelly A; Turco F; DI Stefano RF; Parente A; Bungaro M; Angusti T;
Treatment intensification for metastatic prostate cancer: New treatment landscapes in androgen deprivation-based therapy. in Cancer communications (London, England) / Cancer Commun (Lond). 2022 Aug;42(8):683-688. doi: 10.1002/cac2.12340. Epub 2022 Jul 22.
2022
ASL Asti
ASL Cuneo 2
ASL Torino 4
ASL Cuneo 1
AO Ordine Mauriziano
AOU San Luigi di Orbassano
Buttigliero C; Ortega C; Audisio M; Pisano C; Di Maio M; Ungaro A; Turco F; Tucci M; Audisio A; Di Stefano RF; Delcuratolo MD; Scagliotti GV;
A systematic review and meta-analysis of trials assessing PD-1/PD-L1 immune checkpoint inhibitors activity in pre-treated advanced stage malignant mesothelioma. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2022 Apr;172:103639. doi: 10.1016/j.critrevonc.2022.103639. Epub 2022 Feb 19
2022
ASL Asti
AOU Città della Salute di Torino
ASL Torino 4
AO Ordine Mauriziano
AOU San Luigi di Orbassano
Capelletto E; Scagliotti GV; Novello S; Buffoni L; Di Maio M; Passiglia F; Carnio S; Zichi C; Reale ML; Artusio E; Olmetto E; Paratore C; Bungaro M; Audisio M; Bertaglia V; Tagliamento M; Pignataro D; Rapetti SG; De Luca E; Bironzo P; Curcio H;
Experience with denosumab (XGEVA®) for prevention of skeletal-related events in the 10 years after approval. in Journal of bone oncology / J Bone Oncol. 2022 Feb 7;33:100416. doi: 10.1016/j.jbo.2022.100416. eCollection 2022 Apr.
2022
ASL Torino 4
AOU San Luigi di Orbassano
Scagliotti GV; Saad F; Orlowski RZ; Lipton A; Jafarinasabian P; Coleman R; Cadieux B; Shimizu K; Stopeck A;
Talazoparib monotherapy in metastatic castration-resistant prostate cancer with DNA repair alterations (TALAPRO-1): an open-label, phase 2 trial. in The Lancet. Oncology / Lancet Oncol. 2021 Sep;22(9):1250-1264. doi: 10.1016/S1470-2045(21)00376-4. Epub 2021 Aug 10.
2021
AOU San Luigi di Orbassano
de Bono JS; Mehra N; Scagliotti GV; Castro E; Dorff T; Stirling A; Stenzl A; Fleming MT; Higano CS; Saad F; Buttigliero C; van Oort IM; Laird AD; Mata M; Chen HC; Healy CG; Czibere A; Fizazi K;
Repositioning PARP inhibitors in the treatment of thoracic malignancies. in Cancer treatment reviews / Cancer Treat Rev. 2021 Sep;99:102256. doi: 10.1016/j.ctrv.2021.102256. Epub 2021 Jul 7.
2021
AOU San Luigi di Orbassano
Passiglia F; Reale ML; Cetoretta V; Parlagreco E; Jacobs F; Listì A; Righi L; Bironzo P; Novello S; Scagliotti GV;
Liquid Biopsy for Advanced NSCLC: A Consensus Statement From the International Association for the Study of Lung Cancer. in Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer / J Thorac Oncol. 2021 Oct;16(10):1647-1662. doi: 10.1016/j.jtho.2021.06.017. Epub 2021 Jul 8.
2021
AOU San Luigi di Orbassano
Rolfo C; Mack P; Scagliotti GV; Aggarwal C; Arcila ME; Barlesi F; Bivona T; Diehn M; Dive C; Dziadziuszko R; Leighl N; Malapelle U; Mok T; Peled N; Raez LE; Sequist L; Sholl L; Swanton C; Abbosh C; Tan D; Wakelee H; Wistuba I; Bunn R; Freeman-Daily J; Wynes M; Belani C; Mitsudomi T; Gandara D;
Clinical and Molecular Features of Epidermal Growth Factor Receptor (EGFR) Mutation Positive Non-Small-Cell Lung Cancer (NSCLC) Patients Treated with Tyrosine Kinase Inhibitors (TKIs): Predictive and Prognostic Role of Co-Mutations. in Cancers / Cancers (Basel). 2021 May 17;13(10):2425. doi: 10.3390/cancers13102425.
2021
AO Ordine Mauriziano
AOU San Luigi di Orbassano
Scagliotti GV; Bussolino F; Righi L; Di Maio M; Passiglia F; Caglio A; Listì A; Sperone T; Tabbò F; Reale ML; Bironzo P; Novello S;
Evaluation of the Preclinical Efficacy of Lurbinectedin in Malignant Pleural Mesothelioma. in Cancers / Cancers (Basel). 2021 May 12;13(10):2332. doi: 10.3390/cancers13102332.
2021
AO Alessandria
AOU Città della Salute di Torino
AOU San Luigi di Orbassano
Novello S; Aviles P; Libener R; Leo F; Sandri A; Guerrera F; Comunanza V; Bussolino F; Gigliotti C; Di Nicolantonio F; Pittaro A; Papotti MG; Napoli F; Righi L; Morena D; Lingua MF; Picca F; Bironzo P; Anobile DP; Taulli R; Scagliotti GV; Riganti C;
Renal cell carcinoma (RCC): fatter is better? A review on the role of obesity in RCC. in Endocrine-related cancer / Endocr Relat Cancer. 2021 Jun 2;28(7):R207-R216. doi: 10.1530/ERC-20-0457.
2021
ASL Asti
ASL Vercelli
AO Ordine Mauriziano
AOU San Luigi di Orbassano
Scagliotti GV; Di Maio M; Pisano C; Audisio M; Bungaro M; Samuelly A; Tucci M; Di Stefano RF; Turco F; Buttigliero C;
DNA Methylation Profiling Discriminates between Malignant Pleural Mesothelioma and Neoplastic or Reactive Histologic Mimics. in The Journal of molecular diagnostics : JMD / J Mol Diagn. 2021 Jul;23(7):834-846. doi: 10.1016/j.jmoldx.2021.04.002. Epub 2021 Apr 20.
2021
AOU San Luigi di Orbassano
AOU Città della Salute di Torino
Cassoni P; Papotti M; Bironzo P; Scagliotti GV; Vokuhl C; Fröhling S; Flucke U; Petersen I; von Deimling A; Schrimpf D; Hou Y; Stichel D; Koelsche C; Collemi G; Righi L; Bertero L;
Interactions between androgen receptor signaling and other molecular pathways in prostate cancer progression: Current and future clinical implications. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2021 Jan;157:103185. doi: 10.1016/j.critrevonc.2020.103185. Epub 2020 Nov 27
2021
ASL Asti
AOU San Luigi di Orbassano
ASL Vercelli
AO Ordine Mauriziano
Buttigliero C; Di Maio M; Scagliotti GV; Turco F; Di Stefano RF; Tucci M; Pisano C;
A Prospective Phase II Single-arm Study of Niraparib Plus Dostarlimab in Patients With Advanced Non-small-cell Lung Cancer and/or Malignant Pleural Mesothelioma, Positive for PD-L1 Expression and Germline or Somatic Mutations in the DNA Repair Genes: Rationale and Study Design. in Clinical lung cancer / Clin Lung Cancer. 2021 Jan;22(1):e63-e66. doi: 10.1016/j.cllc.2020.07.014. Epub 2020 Aug 5.
2021
AOU San Luigi di Orbassano
Scagliotti GV; Volante M; Novello S; Arizio F; Listì A; Righi L; Passiglia F; Bironzo P;
Humoral immune response to SARS-CoV-2 in five different groups of individuals at different environmental and professional risk of infection. in Scientific reports / Sci Rep. 2021 Dec 30;11(1):24503. doi: 10.1038/s41598-021-04279-4.
2021
AOU San Luigi di Orbassano
Novello S; Terzolo M; Paola B; Gianetta M; Bianco V; Arizio F; Brero D; Perini AME; Boccuzzi A; Caramello V; Perboni A; Bellavia F; Scagliotti GV;
Prognostic role of platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio in patients with metastatic castration resistant prostate cancer treated with abiraterone or enzalutamide. in Minerva urology and nephrology / Minerva Urol Nephrol. 2021 Dec;73(6):803-814. doi: 10.23736/S2724-6051.21.04186-2. Epub 2021 Mar 29.
2021
ASL Asti
AOU San Luigi di Orbassano
ASL Vercelli
ASL Torino 4
AO Ordine Mauriziano
Buttigliero C; DI Maio M; Scagliotti GV; Tarenghi F; Vignani F; Bungaro M; Samuelly A; Turco F; DI Stefano RF; Tucci M; Pisano C;
Are tyrosine kinase inhibitors an effective treatment in testicular metastases from kidney cancer? Case report. in Tumori / Tumori. 2021 Dec;107(6):NP149-NP154. doi: 10.1177/03008916211059230. Epub 2021 Nov 11.
2021
ASL Asti
AOU San Luigi di Orbassano
Buttigliero C; Scagliotti GV; Bollito E; Bungaro M; Samuelly A; Di Stefano RF; Tucci M; Turco F;
Systemic recurrence of endometrial cancer more than 10?years after hysterectomy: a report of two cases and a brief review of the literature. in Journal of the Egyptian National Cancer Institute / J Egypt Natl Canc Inst. 2020 Nov 2;32(1):41. doi: 10.1186/s43046-020-00052-2.
2020
AOU San Luigi di Orbassano
Scagliotti GV; La Salvia A; Gorzegno G; Sperone P; Muratori L;
Carcinoid heart failure in a duodenal neuroendocrine tumor: role of cardiac surgery in a challenging patient and brief review of the literature. in Acta oncologica (Stockholm, Sweden) / Acta Oncol. 2020 Mar;59(3):315-319. doi: 10.1080/0284186X.2019.1672891. Epub 2019 Oct 4.
2020
AOU San Luigi di Orbassano
AO Ordine Mauriziano
Atzeni F; Di Maio M; Scagliotti GV; Muratori L; Parisi F; Brizzi MP; Trevisi E; La Salvia A;
Immune Checkpoint Inhibitors in Thoracic Malignancies: Review of the Existing Evidence by an IASLC Expert Panel and Recommendations. in Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer / J Thorac Oncol. 2020 Jun;15(6):914-947. doi: 10.1016/j.jtho.2020.03.006. Epub 2020 Mar 14.
2020
AOU San Luigi di Orbassano
Skoulidis F; Schalper KA; Popat S; Paz-Ares L; Mezquita L; Lu S; Kubota K; Horn L; Herbst RS; Goldberg SB; Gettinger S; Forde PM; Garon EB; Barlesi F; Ahn MJ; Passiglia F; Remon J; Reck M; Adjei AA; Scagliotti GV;
Neuroendocrine breast carcinoma: a rare but challenging entity. in Medical oncology (Northwood, London, England) / Med Oncol. 2020 Jul 25;37(8):70. doi: 10.1007/s12032-020-01396-4.
2020
AO Ordine Mauriziano
AOU San Luigi di Orbassano
Di Maio M; De Rosa G; Scagliotti GV; Brizzi MP; La Salvia A; Daniele L; Trevisi E;
Wnt/IL-1?/IL-8 autocrine circuitries control chemoresistance in mesothelioma initiating cells by inducing ABCB5. in International journal of cancer / Int J Cancer. 2020 Jan 1;146(1):192-207. doi: 10.1002/ijc.32419. Epub 2019 Jun 4.
2020
AOU San Luigi di Orbassano
Riganti C; Novello S; Bussolino F; Righi L; Alexa-Stratulat T; Comunanza V; Grosso F; Tabbò F; Ananthanarayanan P; Bironzo P; Orecchia S; Napoli F; Izzo S; Libener R; Scagliotti GV; Salaroglio IC; Kopecka J; Milosevic V;
Quality of life analysis in lung cancer: A systematic review of phase III trials published between 2012 and 2018. in Lung cancer (Amsterdam, Netherlands) / Lung Cancer. 2020 Jan;139:47-54. doi: 10.1016/j.lungcan.2019.10.022. Epub 2019 Oct 31.
2020
AO Ordine Mauriziano
AOU San Luigi di Orbassano
Di Maio M; Perrone F; Novello S; Scagliotti GV; Aglietta M; Bironzo P; Sonetto C; La Salvia A; Muratori L; Trevisi E; Leone G; Mariniello A; Di Stefano RF; Pignataro D; Ghisoni E; Zichi C; Marandino L; Lombardi P; De Luca E; Reale ML;
Exploratory analysis of front-line therapies in REVEL: a randomised phase 3 study of ramucirumab plus docetaxel versus docetaxel for the treatment of stage IV non-small-cell lung cancer after disease progression on platinum-based therapy. in ESMO open / ESMO Open. 2020 Jan;5(1):e000567. doi: 10.1136/esmoopen-2019-000567.
2020
AOU San Luigi di Orbassano
Lee P; Wolff K; Alexandris E; Oton AB; Zimmermann AH; Orlov SV; Cuyun Carter G; Brustugun OT; Gans S; Kim JH; Kalofonos H; Iglesias Docampo L; Thomas M; Reck M; Gautschi O; Scagliotti GV; Garon EB; Stefaniak VJ; Socinski MA; Pérol M;
Quality of life assessment and reporting in colorectal cancer: A systematic review of phase III trials published between 2012 and 2018. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2020 Feb;146:102877. doi: 10.1016/j.critrevonc.2020.102877. Epub 2020 Jan 18
2020
AO Ordine Mauriziano
AOU San Luigi di Orbassano
Perrone F; Scagliotti GV; Aglietta M; Novello S; Leone F; Sonetto C; La Salvia A; Muratori L; Leone G; Trevisi E; Mariniello A; Ghisoni E; Di Stefano RF; Pignataro D; Reale ML; De Luca E; Zichi C; Marandino L; Lombardi P; Di Maio M;
Resistance to anaplastic lymphoma kinase inhibitors: knowing the enemy is half the battle won. in Translational lung cancer research / Transl Lung Cancer Res. 2020 Dec;9(6):2545-2556. doi: 10.21037/tlcr-20-372.
2020
AOU San Luigi di Orbassano
Scagliotti GV; Bironzo P; Reale ML; Tabbò F;
Prognostic role of early PSA drop in castration resistant prostate cancer patients treated with abiraterone acetate or enzalutamide. in Minerva urologica e nefrologica = The Italian journal of urology and nephrology / Minerva Urol Nefrol. 2020 Dec;72(6):737-745. doi: 10.23736/S0393-2249.20.03708-X. Epub 2020 Apr 10.
2020
AOU San Luigi di Orbassano
AO Ordine Mauriziano
Di Maio M; Numico G; Scagliotti GV; Guglielmini P; Lacidogna G; Turco F; Di Stefano RF; Pisano C; Buttigliero C; Tucci M; Sonetto C; Vignani F;
Bipolar androgen therapy in prostate cancer: Current evidences and future perspectives. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2020 Aug;152:102994. doi: 10.1016/j.critrevonc.2020.102994. Epub 2020 May 24
2020
ASL Asti
AOU San Luigi di Orbassano
ASL Vercelli
AO Ordine Mauriziano
Di Maio M; Scagliotti GV; Vignani F; Turco F; Tabbò F; Di Stefano RF; Pisano C; Buttigliero C; Leone G; Tucci M;
Double immune checkpoint blockade in advanced NSCLC. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2020 Aug;152:102980. doi: 10.1016/j.critrevonc.2020.102980. Epub 2020 May 19
2020
AOU San Luigi di Orbassano
Scagliotti GV; Novello S; Mariniello A; Ramalingam SS;
Ocular metastases from neuroendocrine tumors: A literature review. in Seminars in oncology / Semin Oncol. 2020 Apr-Jun;47(2-3):144-147. doi: 10.1053/j.seminoncol.2020.04.003. Epub 2020 May 6.
2020
AOU San Luigi di Orbassano
Scagliotti GV; Muratori L; Parlagreco E; Trevisi E; Persano I; La Salvia A; Brizzi MP;
Prolonged Adrenal Insufficiency After the Discontinuation of Mitotane Therapy. in Endocrine, metabolic & immune disorders drug targets / Endocr Metab Immune Disord Drug Targets. 2020;20(3):485-487. doi: 10.2174/1871530319666190809144620.
2020
AOU San Luigi di Orbassano
Scagliotti GV; La Salvia A; Puglisi S; Pisano C; Reimondo G; Pia A; Muratori L; Sperone P;
Spread through air spaces (STAS) is a predictor of poor outcome in atypical carcinoids of the lung. in Virchows Archiv : an international journal of pathology / Virchows Arch. 2019 Sep;475(3):325-334. doi: 10.1007/s00428-019-02596-8. Epub 2019 Jun 15.
2019
AOU San Luigi di Orbassano
Volante M; Scagliotti GV; Cassoni P; Gatti G; Massa F; Metovic J; Altinay S; Papotti M;
Quality-of-Life Assessment and Reporting in Prostate Cancer: Systematic Review of Phase 3 Trials Testing Anticancer Drugs Published Between 2012 and 2018. in Clinical genitourinary cancer / Clin Genitourin Cancer. 2019 Oct;17(5):332-347.e2. doi: 10.1016/j.clgc.2019.07.007. Epub 2019 Jul 20
2019
AO Ordine Mauriziano
AOU San Luigi di Orbassano
Novello S; Aglietta M; Tucci M; Buttigliero C; Sonetto C; La Salvia A; Muratori L; Leone G; Trevisi E; Mariniello A; Ghisoni E; Di Stefano RF; Pignataro D; Reale ML; Lombardi P; Zichi C; De Luca E; Marandino L; Scagliotti GV; Perrone F; Di Maio M;
Long term control of luteinized thecoma with sclerosing peritonitis with leuprorelin and tamoxifen treatment. in Gynecologic oncology reports / Gynecol Oncol Rep. 2019 Feb 16;28:44-46. doi: 10.1016/j.gore.2019.02.004. eCollection 2019 May.
2019
AOU San Luigi di Orbassano
AO Ordine Mauriziano
Scagliotti GV; Di Maio M; Andreozzi A; Sperone P; Gorzegno G; Muratori L;
Therapeutic options for first-line metastatic castration-resistant prostate cancer: Suggestions for clinical practise in the CHAARTED and LATITUDE era. in Cancer treatment reviews / Cancer Treat Rev. 2019 Mar;74:35-42. doi: 10.1016/j.ctrv.2019.01.002. Epub 2019 Jan 7.
2019
AOU San Luigi di Orbassano
Scagliotti GV; Veccia A; Rossetti S; Rizzo M; Maines F; Kinspergher S; Di Maio M; Cavaliere C; D'aniello C; Buttigliero C; Tucci M; Caffo O; Facchini G;
Definition of Synchronous Oligometastatic Non-Small Cell Lung Cancer-A Consensus Report. in Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer / J Thorac Oncol. 2019 Dec;14(12):2109-2119. doi: 10.1016/j.jtho.2019.07.025. Epub 2019 Aug 6.
2019
AOU San Luigi di Orbassano
Peters S; Porta RR; Infante M; Dziadziuszko R; Gietema H; Cufer T; Ekman S; McDonald F; Paz-Ares L; Guckenberger M; Senan S; Scagliotti GV; Peled N; Gaga M; Lievens Y; Ramella S; Postmus PE; Van Schil P; Smit EF; Reck M; O'Brien M; Edwards J; Lantuéjoul S; Greillier L; Girard N; Giaj-Levra N; Giaj-Levra M; Faivre-Finn C; Hasan B; et alii...
Potential Diagnostic and Prognostic Role of Microenvironment in Malignant Pleural Mesothelioma. in Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer / J Thorac Oncol. 2019 Aug;14(8):1458-1471. doi: 10.1016/j.jtho.2019.03.029. Epub 2019 May 9.
2019
AO Ordine Mauriziano
AOU San Luigi di Orbassano
AOU Città della Salute di Torino
Papotti M; Di Maio M; Novello S; Righi L; Bussolino F; Ruffini E; Ardissone F; Comunanza V; Passone E; Cartia CF; Tabbò F; Bironzo P; Milosevic V; Ananthanarayanan P; Gagliasso M; Costardi L; Maletta F; Pradotto M; Salaroglio IC; Kopecka J; Napoli F; Scagliotti GV; Riganti C;
First-line immune-chemotherapy combination: the right strategy to fight squamous non-small cell lung cancer? in Translational lung cancer research / Transl Lung Cancer Res. 2019 Aug;8(4):546-549. doi: 10.21037/tlcr.2019.04.05.
2019
AOU San Luigi di Orbassano
Scagliotti GV; Bironzo P; Passiglia F;
Long-term disease control and high clinical benefit in a patient with advanced thyroid cancer treated with lenvatinib. in Future oncology (London, England) / Future Oncol. 2019 Aug;15(24s):3-6. doi: 10.2217/fon-2019-0092. Epub 2019 Aug 6.
2019
AOU San Luigi di Orbassano
Scagliotti GV; Sperone P; Muratori L;
Capecitabine plus temozolomide in well- or moderately-differentiated primary atypical neuroendocrine tumours - single-centre experience of two cases. in Endokrynologia Polska / Endokrynol Pol. 2019;70(4):380-383. doi: 10.5603/EP.a2018.0076. Epub 2018 Oct 25.
2019
AOU San Luigi di Orbassano
Di Maio M; Trevisi E; Muratori L; Brizzi MP; La Salvia A; Scagliotti GV;
Quality-of-life (QoL) assessment and reporting in prostate cancer: A systematic review of phase III trials published between 2012 and 2016 in Journal of Clinical Oncology
2019
AO Ordine Mauriziano
AOU San Luigi di Orbassano
Marandino L; La Salvia A; Sonetto C; De Luca E; Pignataro D; Zichi C; Di Stefano RF; Ghisoni E; Lombardi P; Mariniello A; Reale ML; Trevisi E; Leone G; Muratori L; ButtIgliero C; Tucci M; Aglietta M; Scagliotti GV; Perrone F; Di Maio M;
PD-1 is intrinsically expressed by lung cancer cells with stemness features inhibited by PD-1 blockade in Cancer Research
2019
AOU San Luigi di Orbassano
Rotolo R; Leuci V; Donini C; Sanlorenzo M; Vujic I; Medico G; Vita F; Gammaitoni L; Righi L; Riganti C; Vigna E; D'Ambrosio L; Grignani G; Scagliotti GV; Novello S; Aglietta M; Sangiolo D;
Role of radiotherapy in improving activity of immune-modulating drugs in advanced renal cancer: Biological rationale and clinical evidences. in Cancer treatment reviews / Cancer Treat Rev. 2018 Sep;69:215-223. doi: 10.1016/j.ctrv.2018.07.010. Epub 2018 Jul 20.
2018
AO Ordine Mauriziano
AOU San Luigi di Orbassano
AOU Città della Salute di Torino
Di Maio M; Scagliotti GV; Ricardi U; Ruo Redda MG; Di Stefano RF; Leone G; Zichi C; Tucci M; Allis S; Buttigliero C; Filippi AR;
Liquid Biopsy for Advanced Non-Small Cell Lung Cancer (NSCLC): A Statement Paper from the IASLC. in Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer / J Thorac Oncol. 2018 Sep;13(9):1248-1268. doi: 10.1016/j.jtho.2018.05.030. Epub 2018 Jun 6.
2018
AOU San Luigi di Orbassano
Rolfo C; Mack PC; Scagliotti GV; Baas P; Barlesi F; Bivona TG; Herbst RS; Mok TS; Peled N; Pirker R; Raez LE; Reck M; Riess JW; Sequist LV; Shepherd FA; Sholl LM; Tan DSW; Wakelee HA; Wistuba II; Wynes MW; Carbone DP; Hirsch FR; Gandara DR;
Update on International Cooperative Groups Studies in Thoracic Malignancies: The Emergence of Immunotherapy. in Clinical lung cancer / Clin Lung Cancer. 2018 Sep;19(5):377-386. doi: 10.1016/j.cllc.2018.03.004. Epub 2018 Mar 17.
2018
AOU San Luigi di Orbassano
Shukla ND; Salahudeen AA; Taylor GA; Ramalingam SS; Vokes EE; Goss GD; Decker RH; Kelly K; Scagliotti GV; Mok TS; Wakelee HA;
Thymidine phosphorylase: the unforeseen driver in colorectal cancer treatment? in Future oncology (London, England) / Future Oncol. 2018 May;14(12):1223-1231. doi: 10.2217/fon-2017-0627. Epub 2018 Apr 27.
2018
AOU San Luigi di Orbassano
Tampellini M; Bironzo P; Di Maio M; Scagliotti GV;
Efficacy and safety of everolimus treatment in a hemodialysis patient with metastatic atypical bronchial carcinoid: case report and literature review. in BMC cancer / BMC Cancer. 2018 Mar 20;18(1):311. doi: 10.1186/s12885-018-4205-0.
2018
AOU San Luigi di Orbassano
Brizzi MP; La Salvia A; Tampellini M; Sonetto C; Volante M; Scagliotti GV;
Loss of C/EBP-? LIP drives cisplatin resistance in malignant pleural mesothelioma. in Lung cancer (Amsterdam, Netherlands) / Lung Cancer. 2018 Jun;120:34-45. doi: 10.1016/j.lungcan.2018.03.022. Epub 2018 Mar 26.
2018
AO Ordine Mauriziano
AOU San Luigi di Orbassano
Rubinstein M; Novello S; Di Maio M; Napoli F; Pradotto M; Capelletto E; Ricci L; Ananthanarayanan P; Milosevic V; Grosso F; Libener R; Orecchia S; Salaroglio IC; Righi L; Kopecka J; Scagliotti GV; Riganti C;
Molecular and Histopathological Characterization of the Tumor Immune Microenvironment in Advanced Stage of Malignant Pleural Mesothelioma. in Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer / J Thorac Oncol. 2018 Jan;13(1):124-133. doi: 10.1016/j.jtho.2017.09.1968. Epub 2017 Oct 24.
2018
AOU San Luigi di Orbassano
Patil NS; Righi L; Koeppen H; Zou W; Izzo S; Grosso F; Libener R; Loiacono M; Monica V; Buttigliero C; Novello S; Hegde PS; Papotti M; Kowanetz M; Scagliotti GV;
A systematic review of the safety profile of the different combinations of fluoropyrimidines and oxaliplatin in the treatment of colorectal cancer patients. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2018 Feb;122:21-29. doi: 10.1016/j.critrevonc.2017.12.010. Epub 2017 Dec 16.
2018
AO Ordine Mauriziano
AOU San Luigi di Orbassano
Baratelli C; Zichi C; Di Maio M; Brizzi MP; Sonetto C; Scagliotti GV; Tampellini M;
The Circadian Rhythm of Breakthrough Pain Episodes in Terminally-ill Cancer Patients. in Cancers / Cancers (Basel). 2018 Dec 24;11(1):18. doi: 10.3390/cancers11010018.
2018
AOU San Luigi di Orbassano
Campagna S; Sperlinga R; Milo A; Sannuto S; Acquafredda F; Saini A; Gonella S; Berruti A; Scagliotti GV; Tampellini M;
Deficiencies in health-related quality-of-life assessment and reporting: a systematic review of oncology randomized phase III trials published between 2012 and 2016. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2018 Dec 1;29(12):2288-2295. doi: 10.1093/annonc/mdy449.
2018
AOU San Luigi di Orbassano
Marandino L; La Salvia A; Sonetto C; De Luca E; Pignataro D; Zichi C; Di Stefano RF; Ghisoni E; Lombardi P; Mariniello A; Reale ML; Trevisi E; Leone G; Muratori L; Marcato M; Bironzo P; Novello S; Aglietta M; Scagliotti GV; Perrone F; Di Maio M;
Current Status and Future Perspectives on Neoadjuvant Therapy in Lung Cancer. in Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer / J Thorac Oncol. 2018 Dec;13(12):1818-1831. doi: 10.1016/j.jtho.2018.09.017. Epub 2018 Sep 27.
2018
AOU San Luigi di Orbassano
Blumenthal GM; Bunn PA Jr; Chaft JE; McCoach CE; Perez EA; Scagliotti GV; Carbone DP; Aerts HJWL; Aisner DL; Bergh J; Berry DA; Jarkowski A; Botwood N; Cross DAE; Diehn M; Drezner NL; Doebele RC; Blakely CM; Eberhardt WEE; Felip E; Gianni L; Keller SP; Leavey PJ; Malik S; Pignatti F; Prowell TM; Redman MW; Rizvi NA; Rosell R; et alii...
FOLFOX activity in a rare case of metastatic colonic adenocarcinoma of the tongue: a case report. in BMC cancer / BMC Cancer. 2018 Apr 26;18(1):470. doi: 10.1186/s12885-018-4395-5.
2018
AOU San Luigi di Orbassano
Zichi C; Tampellini M; Tucci M; Sonetto C; Baratelli C; Brizzi MP; Scagliotti GV;
Hormonal treatment and quality of life of prostate cancer patients: new evidence. in Minerva urologica e nefrologica = The Italian journal of urology and nephrology / Minerva Urol Nefrol. 2018 Apr;70(2):144-151. doi: 10.23736/S0393-2249.17.03066-1. Epub 2017 Dec 14.
2018
AOU San Luigi di Orbassano
Tucci M; Leone G; Buttigliero C; Zichi C; DI Stefano RF; Pignataro D; Vignani F; Scagliotti GV; DI Maio M;
MMC/UFT/LV in refractory colorectal cancer: phase II study and analysis of predictive variables of progression. in International journal of clinical oncology / Int J Clin Oncol. 2018 Apr;23(2):281-286. doi: 10.1007/s10147-017-1195-x. Epub 2017 Sep 27.
2018
AOU San Luigi di Orbassano
Baratelli C; Tampellini M; Di Maio M; Ottone A; Brizzi MP; Forti L; Alabiso I; Sonetto C; Alabiso O; Scagliotti GV;
Enzalutamide-resistant castration-resistant prostate cancer: challenges and solutions. in OncoTargets and therapy / Onco Targets Ther. 2018 Oct 24;11:7353-7368. doi: 10.2147/OTT.S153764. eCollection 2018.
2018
AO Ordine Mauriziano
AOU San Luigi di Orbassano
Tucci M; Zichi C; Buttigliero C; Vignani F; Scagliotti GV; Di Maio M;
Bromodomain inhibition exerts its therapeutic potential in malignant pleural mesothelioma by promoting immunogenic cell death and changing the tumor immune-environment. in Oncoimmunology / Oncoimmunology. 2017 Nov 27;7(3):e1398874. doi: 10.1080/2162402X.2017.1398874. eCollection 2018.
2018
AOU San Luigi di Orbassano
Bussolino F; Comunanza V; Bironzo P; Orecchia S; Libener R; Pradotto M; Kopecka J; Picca F; Oddo D; Morena D; Falcomatà C; Righi L; Salaroglio IC; Lingua MF; Riganti C; Novello S; Scagliotti GV; Di Nicolantonio F; Taulli R;
Biases in assessment and reporting of health-related quality of life (QoL): A systematic review of oncology randomized phase III trials published between 2012 and 2016 in Journal of Clinical Oncology
2018
AO Ordine Mauriziano
AOU San Luigi di Orbassano
Marandino L; La Salvia A; Sonetto C; De Luca E; Pignataro D; Zichi C; Di Stefano RF; Ghisoni E; Lombardi P; Mariniello A; Reale ML; Trevisi E; Leone G; Muratori L; Marcato M; Bironzo P; Aglietta M; Scagliotti GV; Perrone F; Di Maio M;
Precision medicine in age-specific non-small-cell-lung-cancer patients: Integrating biomolecular results into clinical practice-A new approach to improve personalized translational research. in Lung cancer (Amsterdam, Netherlands) / Lung Cancer. 2017 May;107:84-90. doi: 10.1016/j.lungcan.2016.05.021. Epub 2016 May 31.
2017
AOU San Luigi di Orbassano
Vavalà T; Monica V; Lo Iacono M; Mele T; Busso S; Righi L; Papotti M; Scagliotti GV; Novello S;
Molecular biomarkers to predict response to neoadjuvant chemotherapy for bladder cancer. in Cancer treatment reviews / Cancer Treat Rev. 2017 Mar;54:1-9. doi: 10.1016/j.ctrv.2017.01.002. Epub 2017 Jan 11.
2017
AOU San Luigi di Orbassano
Buttigliero C; Tucci M; Vignani F; Scagliotti GV; Di Maio M;
Tissue Expression and Pharmacological In Vitro Analyses of mTOR and SSTR Pathways in Adrenocortical Carcinoma. in Endocrine pathology / Endocr Pathol. 2017 Jun;28(2):95-102. doi: 10.1007/s12022-017-9473-8.
2017
AOU San Luigi di Orbassano
Germano A; Rapa I; Duregon E; Votta A; Giorcelli J; Buttigliero C; Scagliotti GV; Volante M; Terzolo M; Papotti M;
Topoisomerase 2? and thymidylate synthase expression in adrenocortical cancer. in Endocrine-related cancer / Endocr Relat Cancer. 2017 Jul;24(7):319-327. doi: 10.1530/ERC-17-0095. Epub 2017 Apr 21.
2017
AOU San Luigi di Orbassano
Roca E; Berruti A; Sbiera S; Rapa I; Oneda E; Sperone P; Ronchi CL; Ferrari L; Grisanti S; Germano A; Zaggia B; Scagliotti GV; Fassnacht M; Volante M; Terzolo M; Papotti M;
Lung cancer: current therapies and new targeted treatments. in Lancet (London, England) / Lancet. 2017 Jan 21;389(10066):299-311. doi: 10.1016/S0140-6736(16)30958-8. Epub 2016 Aug 27.
2017
AOU San Luigi di Orbassano
Hirsch FR; Scagliotti GV; Mulshine JL; Kwon R; Curran WJ Jr; Wu YL; Paz-Ares L;
Meta-analysis examining impact of age on overall survival with pemetrexed for the treatment of advanced non-squamous non-small cell lung cancer. in Lung cancer (Amsterdam, Netherlands) / Lung Cancer. 2017 Feb;104:45-51. doi: 10.1016/j.lungcan.2016.12.007. Epub 2016 Dec 12.
2017
AOU San Luigi di Orbassano
Paz-Ares LG; Zimmermann A; Ciuleanu T; Bunn PA; Antonio BS; Denne J; Iturria N; John W; Scagliotti GV;
Treatment of Patients With Metastatic Colorectal Cancer in a Real-World Scenario: Probability of Receiving Second and Further Lines of Therapy and Description of Clinical Benefit. in Clinical colorectal cancer / Clin Colorectal Cancer. 2017 Dec;16(4):372-376. doi: 10.1016/j.clcc.2017.03.019. Epub 2017 Apr 8.
2017
AOU San Luigi di Orbassano
Tampellini M; Di Maio M; Baratelli C; Anania L; Brizzi MP; Sonetto C; La Salvia A; Scagliotti GV;
Scientific Advances in Thoracic Oncology 2016. in Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer / J Thorac Oncol. 2017 Aug;12(8):1183-1209. doi: 10.1016/j.jtho.2017.05.019. Epub 2017 Jun 1.
2017
AOU San Luigi di Orbassano
Soo RA; Stone ECA; Cummings KM; Jett JR; Field JK; Groen HJM; Mulshine JL; Yatabe Y; Bubendorf L; Dacic S; Rami-Porta R; Detterbeck FC; Lim E; Asamura H; Donington J; Wakelee HA; Wu YL; Higgins K; Senan S; Solomon B; Kim DW; Johnson M; Yang JCH; Sequist LV; Shaw AT; Ahn MJ; Costa DB; Patel JD; Horn L; et alii...
An exploratory analysis of the association between levels of hormones implied in steroid biosynthesis and activity of abiraterone in patients with metastatic castration-resistant prostate cancer. in Minerva urologica e nefrologica = The Italian journal of urology and nephrology / Minerva Urol Nefrol. 2017 Aug;69(4):349-358. doi: 10.23736/S0393-2249.16.02746-6. Epub 2016 Dec 22.
2017
AOU San Luigi di Orbassano
Bertaglia V; Tucci M; Vignani F; Buttigliero C; Aroasio E; Berruti A; Scagliotti GV; DI Maio M;
Immunotherapy for Patients with Advanced Urothelial Cancer: Current Evidence and Future Perspectives. in BioMed research international / Biomed Res Int. 2017;2017:5618174. doi: 10.1155/2017/5618174. Epub 2017 Jun 7.
2017
AOU San Luigi di Orbassano
AO Ordine Mauriziano
Di Maio M; Scagliotti GV; Pignataro D; Vignani F; Buttigliero C; Leone G; Tucci M; Zichi C;
Scientific Advances in Lung Cancer 2015. in Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer / J Thorac Oncol. 2016 May;11(5):613-638. doi: 10.1016/j.jtho.2016.03.012. Epub 2016 Mar 22.
2016
AOU San Luigi di Orbassano
Tsao AS; Scagliotti GV; Bunn PA Jr; Carbone DP; Warren GW; Bai C; de Koning HJ; Yousaf-Khan AU; McWilliams A; Tsao MS; Adusumilli PS; Rami-Porta R; Asamura H; Van Schil PE; Darling GE; Ramalingam SS; Gomez DR; Rosenzweig KE; Zimmermann S; Peters S; Ignatius Ou SH; Reungwetwattana T; Jänne PA; Mok TS; Wakelee HA; Pirker R; Mazières J; Brahmer JR; Zhou Y; et alii...
Skeletal metastases and impact of anticancer and bone-targeted agents in patients with castration-resistant prostate cancer. in Cancer treatment reviews / Cancer Treat Rev. 2016 Mar;44:61-73. doi: 10.1016/j.ctrv.2016.02.002. Epub 2016 Feb 12.
2016
AOU San Luigi di Orbassano
Vignani F; Bertaglia V; Buttigliero C; Tucci M; Scagliotti GV; Di Maio M;
Raising the bar for enthusiasm when looking at results of randomized phase II trials-the case of sunitinib in small-cell lung cancer. in Translational lung cancer research / Transl Lung Cancer Res. 2016 Feb;5(1):89-91. doi: 10.3978/j.issn.2218-6751.2015.07.18.
2016
AOU San Luigi di Orbassano
Di Maio M; Bironzo P; Scagliotti GV;
Novel investigational therapies for treating biliary tract carcinoma. in Expert opinion on investigational drugs / Expert Opin Investig Drugs. 2016 Dec;25(12):1423-1436. doi: 10.1080/13543784.2016.1252330. Epub 2016
2016
AOU San Luigi di Orbassano
Tampellini M; La Salvia A; Scagliotti GV;
Changes in hepatic perfusion assessed by dynamic contrast enhanced MRI, associated with morphologic evaluation, in patients with liver metastases from colorectal cancer treated with first-line chemotherapy. in La Radiologia medica / Radiol Med. 2016 Dec;121(12):950-957. doi: 10.1007/s11547-016-0685-7. Epub 2016 Sep 6.
2016
AOU San Luigi di Orbassano
Tampellini M; Gned D; Baratelli C; Brizzi MP; Ottone A; Alabiso I; Bertaggia C; Di Maio M; Scagliotti GV; Veltri A;
Retrospective Multicenter Study Investigating the Role of Targeted Next-Generation Sequencing of Selected Cancer Genes in Mucinous Adenocarcinoma of the Lung. in Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer / J Thorac Oncol. 2016 Apr;11(4):504-15. doi: 10.1016/j.jtho.2016.01.004. Epub 2016 Jan 13.
2016
AOU San Luigi di Orbassano
Righi L; Vatrano S; Di Nicolantonio F; Massa F; Rossi G; Cavazza A; Volante M; Votta A; Izzo S; Lo Iacono M; Ardissone F; Di Maio M; Novello S; Scagliotti GV; Papotti M;
Does nephrectomy during radical adrenalectomy for stage II adrenocortical cancer affect patient outcome? in Journal of endocrinological investigation / J Endocrinol Invest. 2016 Apr;39(4):465-71. doi: 10.1007/s40618-015-0422-4. Epub 2015 Dec 22.
2016
AOU San Luigi di Orbassano
Porpiglia F; Fiori C; Daffara FC; Zaggia B; Ardito A; Scarpa RM; Papotti M; Berruti A; Scagliotti GV; Terzolo M;
Addition of Docetaxel to Androgen Deprivation Therapy for Patients with Hormone-sensitive Metastatic Prostate Cancer: A Systematic Review and Meta-analysis. in European urology / Eur Urol. 2016 Apr;69(4):563-573. doi: 10.1016/j.eururo.2015.09.013. Epub 2015 Sep 28.
2016
AOU San Luigi di Orbassano
Tucci M; Bertaglia V; Vignani F; Buttigliero C; Fiori C; Porpiglia F; Scagliotti GV; Di Maio M;
Molecular and Histological Changes in Post-Treatment Biopsies of Non-Squamous Non-Small Cell Lung Cancer: A Retrospective Study. in Targeted oncology / Target Oncol. 2016 Apr;11(2):157-66. doi: 10.1007/s11523-015-0383-8.
2016
AOU San Luigi di Orbassano
Vatrano S; Righi L; Vavalá T; Rapa I; Busso M; Izzo S; Cappia S; Veltri A; Papotti M; Scagliotti GV; Novello S;
Novel anti-angiogenic therapeutic strategies in colorectal cancer. in Expert opinion on investigational drugs / Expert Opin Investig Drugs. 2016;25(5):507-20. doi: 10.1517/13543784.2016.1161754. Epub 2016 Mar 24.
2016
AOU San Luigi di Orbassano
Tampellini M; Sonetto C; Scagliotti GV;
Bioequivalence of branded and generic oxaliplatin: From preclinical assessment to clinical incidence of hypersensitivity reactions in Anticancer Research
2016
AOU San Luigi di Orbassano
Tampellini M; Benedetto S; Rubatto E; Baratelli C; Di Scipio F; Pirro E; Brizzi MP; Sonetto C; Di Maio M; Berta GN; Scagliotti GV;
The fat body mass increase after adjuvant androgen deprivation therapy is predictive of prostate cancer outcome. in Endocrine / Endocrine. 2015 Sep;50(1):223-30. doi: 10.1007/s12020-015-0525-x. Epub 2015 Jan 15.
2015
AOU San Luigi di Orbassano
Buttigliero C; Vana F; Bertaglia V; Vignani F; Fiori C; Osella G; Porpiglia F; Tucci M; Scagliotti GV; Berruti A;
Tivantinib added to erlotinib in nonsmall-cell lung cancer: the primary end point was not MET... in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2015 Oct;26(10):2007-9. doi: 10.1093/annonc/mdv334. Epub 2015 Aug 11.
2015
AOU San Luigi di Orbassano
Scagliotti GV; Di Maio M;
Unusual paraneoplastic neurological syndrome secondary to a well differentiated pancreatic neuroendocrine tumor: a case report and review of the literature. in BMC cancer / BMC Cancer. 2015 Nov 18;15:914. doi: 10.1186/s12885-015-1923-4.
2015
AOU San Luigi di Orbassano
Brizzi MP; Sonetto C; Tampellini M; Di Maio M; Volante M; Scagliotti GV;
Biological and clinical effects of abiraterone on anti-resorptive and anabolic activity in bone microenvironment. in Oncotarget / Oncotarget. 2015 May 20;6(14):12520-8. doi: 10.18632/oncotarget.3724.
2015
AOU San Luigi di Orbassano
Iuliani M; Pantano F; Buttigliero C; Fioramonti M; Bertaglia V; Vincenzi B; Zoccoli A; Ribelli G; Tucci M; Vignani F; Berruti A; Scagliotti GV; Tonini G; Santini D;
The prognostic role of baseline CEA and CA 19-9 values and their time-dependent variations in advanced colorectal cancer patients submitted to first-line therapy. in Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine / Tumour Biol. 2015 Mar;36(3):1519-27. doi: 10.1007/s13277-014-2693-3. Epub 2014 Nov 6.
2015
AOU San Luigi di Orbassano
ASL Città di Torino
Tampellini M; Ottone A; Alabiso I; Baratelli C; Forti L; Berruti A; Aroasio E; Scagliotti GV;
ATF2 contributes to cisplatin resistance in non-small cell lung cancer and celastrol induces cisplatin resensitization through inhibition of JNK/ATF2 pathway. in International journal of cancer / Int J Cancer. 2015 Jun 1;136(11):2598-609. doi: 10.1002/ijc.29302. Epub 2014 Nov 12.
2015
AOU San Luigi di Orbassano
Lo Iacono M; Monica V; Vavalà T; Gisabella M; Saviozzi S; Bracco E; Novello S; Papotti M; Scagliotti GV;
Pitfalls in the diagnosis of adrenocortical tumors: a lesson from 300 consultation cases. in Human pathology / Hum Pathol. 2015 Dec;46(12):1799-807. doi: 10.1016/j.humpath.2015.08.012. Epub 2015 Sep 11.
2015
AOU San Luigi di Orbassano
Duregon E; Volante M; Bollito E; Goia M; Buttigliero C; Zaggia B; Berruti A; Scagliotti GV; Papotti M;
Understanding and overcoming the mechanisms of primary and acquired resistance to abiraterone and enzalutamide in castration resistant prostate cancer. in Cancer treatment reviews / Cancer Treat Rev. 2015 Dec;41(10):884-92. doi: 10.1016/j.ctrv.2015.08.002. Epub 2015 Aug 31.
2015
AOU San Luigi di Orbassano
Buttigliero C; Tucci M; Bertaglia V; Vignani F; Bironzo P; Di Maio M; Scagliotti GV;
Alberta Breakthrough Pain Assessment Tool: A validation multicentre study in cancer patients with breakthrough pain. in European journal of pain (London, England) / Eur J Pain. 2015 Aug;19(7):881-8. doi: 10.1002/ejp.612. Epub 2014 Nov 5.
2015
AOU San Luigi di Orbassano
AOU Città della Salute di Torino
Sperlinga R; Campagna S; Berruti A; Laciura P; Ginosa I; Paoletti S; Giuliano PL; Tucci M; Rosato R; Scagliotti GV; Saini A;
Identification of MicroRNAs Differentially Expressed in Lung Carcinoid Subtypes and Progression. in Neuroendocrinology / Neuroendocrinology. 2015;101(3):246-55. doi: 10.1159/000381454. Epub 2015 Mar 16.
2015
AOU San Luigi di Orbassano
Rapa I; Votta A; Felice B; Righi L; Giorcelli J; Scarpa A; Speel EJ; Scagliotti GV; Papotti M; Volante M;
Expression analysis of genes involved in DNA repair or synthesis in mixed neuroendocrine/nonneuroendocrine carcinomas. in Neuroendocrinology / Neuroendocrinology. 2015;101(2):151-60. doi: 10.1159/000375449. Epub 2015 Jan 29.
2015
AOU San Luigi di Orbassano
Volante M; Monica V; Birocco N; Brizzi MP; Busso S; Daniele L; La Rosa S; Righi L; Sapino A; Berruti A; Scagliotti GV; Papotti M;
Metastatic castration-resistant prostate cancer: time for innovation. in Future oncology (London, England) / Future Oncol. 2015;11(1):91-106. doi: 10.2217/fon.14.145.
2015
AOU San Luigi di Orbassano
Tucci M; Scagliotti GV; Vignani F;
Association between levels of hormones implied in steroid biosynthesis pathway and activity of abiraterone acetate (AA) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC): An exploratory analysis in Journal of Clinical Oncology
2015
AOU San Luigi di Orbassano
Tucci M; Vignani F; Bertaglia V; Buttigliero C; Berruti A; Scagliotti GV; Di Maio M;
Validation of ERCC1 (E1) for response prediction to platinumgemcitabine in Journal of Clinical Oncology
2015
AOU San Luigi di Orbassano
Bepler G; Chen W; Patrick S; Astrow SH; Stephens C; Gandara DR; Rosell R; Ramirez JL; Scagliotti GV; Busso S; Volante M; Novello S;
Efficacy and safety of maintenance pemetrexed in patients with advanced nonsquamous non-small cell lung cancer following pemetrexed plus cisplatin induction treatment: A cross-trial comparison of two phase III trials. in Lung cancer (Amsterdam, Netherlands) / Lung Cancer. 2014 Sep;85(3):408-14. doi: 10.1016/j.lungcan.2014.07.005. Epub 2014 Jul 16.
2014
AOU San Luigi di Orbassano
Scagliotti GV; Gridelli C; de Marinis F; Thomas M; Dediu M; Pujol JL; Manegold C; San Antonio B; Peterson PM; John W; Chouaki N; Visseren-Grul C; Paz-Ares LG;
Impact of non-small-cell lung cancer-not otherwise specified immunophenotyping on treatment outcome. in Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer / J Thorac Oncol. 2014 Oct;9(10):1540-6. doi: 10.1097/JTO.0000000000000271.
2014
AOU San Luigi di Orbassano
Righi L; Vavalà T; Rapa I; Vatrano S; Giorcelli J; Rossi G; Capelletto E; Novello S; Scagliotti GV; Papotti M;
First-line therapeutic options for advanced non-small-cell lung cancer in the molecular medicine era. in Future oncology (London, England) / Future Oncol. 2014 May;10(6):1081-93. doi: 10.2217/fon.13.247.
2014
AOU San Luigi di Orbassano
Capelletto E; Novello S; Scagliotti GV;
Tumor/stromal caveolin-1 expression patterns in pleural mesothelioma define a subgroup of the epithelial histotype with poorer prognosis. in American journal of clinical pathology / Am J Clin Pathol. 2014 Jun;141(6):816-27. doi: 10.1309/AJCP0F6WYBXGVDHX.
2014
AOU San Luigi di Orbassano
Righi L; Cavallo MC; Gatti G; Monica V; Rapa I; Busso S; Albera C; Volante M; Scagliotti GV; Papotti M;
Moving from histological subtyping to molecular characterization: new treatment opportunities in advanced non-small-cell lung cancer. in Expert review of anticancer therapy / Expert Rev Anticancer Ther. 2014 Dec;14(12):1495-513. doi: 10.1586/14737140.2014.949245. Epub 2014 S
2014
AOU San Luigi di Orbassano
Carnio S; Novello S; Bironzo P; Scagliotti GV;
MicroRNA expression patterns in adrenocortical carcinoma variants and clinical pathologic correlations. in Human pathology / Hum Pathol. 2014 Aug;45(8):1555-62. doi: 10.1016/j.humpath.2014.04.005. Epub 2014 Apr 24.
2014
AOU San Luigi di Orbassano
Duregon E; Rapa I; Votta A; Giorcelli J; Daffara F; Terzolo M; Scagliotti GV; Volante M; Papotti M;
Intermittent everolimus administration for malignant insulinoma. in Endocrinology, diabetes & metabolism case reports / Endocrinol Diabetes Metab Case Rep. 2014;2014:140047. doi: 10.1530/EDM-14-0047. Epub 2014 Sep 1.
2014
AOU San Luigi di Orbassano
Baratelli C; Brizzi MP; Tampellini M; Scagliotti GV; Priola A; Terzolo M; Pia A; Berruti A;
Next-generation sequencing in malignant pleural mesothelioma: A retrospective study in Journal of Clinical Oncology
2014
AOU San Luigi di Orbassano
Scagliotti GV; Iacono ML; Novello S; Libener R; Vatrano S; Righi L; Papotti M; Bironzo P; Monica V; Grosso F;
Histologic and genotypic re-evaluation of non-small cell lung cancer (NSCLC): A monocentric study in Journal of Clinical Oncology
2014
AOU San Luigi di Orbassano
Vavalá T; Busso M; Righi L; Vatrano S; Cappia S; Sardo D; Rapetti SG; Veltri A; Papotti M; Scagliotti GV; Novello S;
Early response to chemotherapy in patients with non-small-cell lung cancer assessed by [18F]-fluoro-deoxy-D-glucose positron emission tomography and computed tomography. in Clinical lung cancer / Clin Lung Cancer. 2013 May;14(3):230-7. doi: 10.1016/j.cllc.2012.10.004. Epub 2012 Dec 29.
2013
AOU San Luigi di Orbassano
Novello S; Vavalà T; Levra MG; Solitro F; Pelosi E; Veltri A; Scagliotti GV;
Current state-of-the-art therapy for advanced squamous cell lung cancer. in American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting / Am Soc Clin Oncol Educ Book. 2013:354-8. doi: 10.14694/EdBook_AM.2013.33.354.
2013
AOU San Luigi di Orbassano
Scagliotti GV; Novello S; Rapetti S; Papotti M;
In reply in Oncologist
2013
AOU San Luigi di Orbassano
Tampellini M; Ardissone F; Scagliotti GV;
Rationale and design of MARQUEE: a phase III, randomized, double-blind study of tivantinib plus erlotinib versus placebo plus erlotinib in previously treated patients with locally advanced or metastatic, nonsquamous, non-small-cell lung cancer. in Clinical lung cancer / Clin Lung Cancer. 2012 Sep;13(5):391-5. doi: 10.1016/j.cllc.2012.01.003. Epub 2012 Mar 21.
2012
AOU San Luigi di Orbassano
Scagliotti GV; Novello S; Schiller JH; Hirsh V; Sequist LV; Soria JC; von Pawel J; Schwartz B; Von Roemeling R; Sandler AB;
Primary pleuropulmonary sarcoma: a rare disease entity. in Clinical lung cancer / Clin Lung Cancer. 2012 Nov;13(6):399-407. doi: 10.1016/j.cllc.2012.05.003. Epub 2012 Jun 5.
2012
AOU San Luigi di Orbassano
Giaj Levra M; Novello S; Scagliotti GV; Papotti M; Le Cesne A;
Role of hormone receptor expression in patients with advanced-stage lung cancer treated with chemotherapy. in Clinical lung cancer / Clin Lung Cancer. 2012 Nov;13(6):416-23. doi: 10.1016/j.cllc.2012.03.006. Epub 2012 Jun 2.
2012
AOU San Luigi di Orbassano
Monica V; Longo M; Felice B; Scagliotti GV; Papotti M; Novello S;
The role of the insulin-like growth factor signaling pathway in non-small cell lung cancer and other solid tumors. in Cancer treatment reviews / Cancer Treat Rev. 2012 Jun;38(4):292-302. doi: 10.1016/j.ctrv.2011.07.008. Epub 2011 Sep 9.
2012
AOU San Luigi di Orbassano
Scagliotti GV; Novello S;
Expression and pharmacological inhibition of thymidylate synthase and Src kinase in nonsmall cell lung cancer. in International journal of cancer / Int J Cancer. 2012 Apr 15;130(8):1777-86. doi: 10.1002/ijc.26188. Epub 2011 Aug 5.
2012
AOU San Luigi di Orbassano
Ceppi P; Rapa I; Lo Iacono M; Righi L; Giorcelli J; Pautasso M; Billè A; Ardissone F; Papotti M; Scagliotti GV;
Differentiation-inducing factor-1 enhances 5-fluorouracil action on oral cancer cells inhibiting E2F1 and thymidylate synthase mRNAs accumulation. in Cancer chemotherapy and pharmacology / Cancer Chemother Pharmacol. 2012 Apr;69(4):983-9. doi: 10.1007/s00280-011-1790-x. Epub 2011 Dec 4.
2012
AOU San Luigi di Orbassano
Sprio AE; Di Scipio F; Ceppi P; Salamone P; Di Carlo F; Scagliotti GV; Papotti M; Ceccarelli A; Berta GN;
The role of lung metastasis resection in improving outcome of colorectal cancer patients: results from a large retrospective study. in The oncologist / Oncologist. 2012;17(11):1430-8. doi: 10.1634/theoncologist.2012-0142. Epub 2012 Sep 6.
2012
AOU San Luigi di Orbassano
AO Ordine Mauriziano
Tampellini M; Ottone A; Bellini E; Alabiso I; Baratelli C; Bitossi R; Brizzi MP; Ferrero A; Sperti E; Leone F; Miraglia S; Forti L; Bertona E; Ardissone F; Berruti A; Alabiso O; Aglietta M; Scagliotti GV;
Pulmonary toxicity related to systemic treatment of nonsmall cell lung cancer. in Cancer / Cancer. 2011 Jul 15;117(14):3069-80. doi: 10.1002/cncr.25894. Epub 2011 Jan 31.
2011
AOU San Luigi di Orbassano
De Sanctis A; Taillade L; Vignot S; Novello S; Conforti R; Spano JP; Scagliotti GV; Khayat D;
Immunohistochemical subtyping of nonsmall cell lung cancer not otherwise specified in fine-needle aspiration cytology: a retrospective study of 103 cases with surgical correlation. in Cancer / Cancer. 2011 Aug 1;117(15):3416-23. doi: 10.1002/cncr.25830. Epub 2011 Jan 18.
2011
AOU San Luigi di Orbassano
Righi L; Graziano P; Fornari A; Rossi G; Barbareschi M; Cavazza A; Pelosi G; Scagliotti GV; Papotti M;
Loss of miR-200c expression induces an aggressive, invasive, and chemoresistant phenotype in non-small cell lung cancer. in Molecular cancer research : MCR / Mol Cancer Res. 2010 Sep;8(9):1207-16. doi: 10.1158/1541-7786.MCR-10-0052. Epub 2010 Aug 9.
2010
AOU San Luigi di Orbassano
Ceppi P; Mudduluru G; Kumarswamy R; Rapa I; Scagliotti GV; Papotti M; Allgayer H;
Thymidylate synthase but not excision repair cross-complementation group 1 tumor expression predicts outcome in patients with malignant pleural mesothelioma treated with pemetrexed-based chemotherapy. in Journal of clinical oncology : official journal of the American Society of Clinical Oncology / J Clin Oncol. 2010 Mar 20;28(9):1534-9. doi: 10.1200/JCO.2009.25.9275. Epub 2010 Feb 22.
2010
AOU San Luigi di Orbassano
Righi L; Papotti MG; Ceppi P; Billè A; Bacillo E; Molinaro L; Ruffini E; Scagliotti GV; Selvaggi G;
A randomized phase II study of bortezomib and pemetrexed, in combination or alone, in patients with previously treated advanced non-small-cell lung cancer. in Lung cancer (Amsterdam, Netherlands) / Lung Cancer. 2010 Jun;68(3):420-6. doi: 10.1016/j.lungcan.2009.07.011. Epub 2009 Aug 18.
2010
AOU San Luigi di Orbassano
Scagliotti GV; Germonpré P; Bosquée L; Vansteenkiste J; Gervais R; Planchard D; Reck M; De Marinis F; Lee JS; Park K; Biesma B; Gans S; Ramlau R; Szczesna A; Makhson A; Manikhas G; Morgan B; Zhu Y; Chan KC; von Pawel J;
Survival without toxicity for cisplatin plus pemetrexed versus cisplatin plus gemcitabine in chemonaïve patients with advanced non-small cell lung cancer: a risk-benefit analysis of a large phase III study. in European journal of cancer (Oxford, England : 1990) / Eur J Cancer. 2009 Sep;45(13):2298-303. doi: 10.1016/j.ejca.2009.04.033. Epub 2009 May 25.
2009
AOU San Luigi di Orbassano
Scagliotti GV; Park K; Patil S; Rolski J; Goksel T; Martins R; Gans SJ; Visseren-Grul C; Peterson P;
Histologic subtype in NSCLC: does it matter? in Oncology (Williston Park, N.Y.) / Oncology (Williston Park). 2009 Nov 30;23(13):1133-40.
2009
AOU San Luigi di Orbassano
Selvaggi G; Scagliotti GV;
Effects of Src kinase inhibition induced by dasatinib in non-small cell lung cancer cell lines treated with cisplatin. in Molecular cancer therapeutics / Mol Cancer Ther. 2009 Nov;8(11):3066-74. doi: 10.1158/1535-7163.MCT-09-0151. Epub 2009 Oct 27.
2009
AOU San Luigi di Orbassano
Ceppi P; Papotti M; Monica V; Lo Iacono M; Saviozzi S; Pautasso M; Novello S; Mussino S; Bracco E; Volante M; Scagliotti GV;
Nonsmall cell lung cancer in never smokers. in Current opinion in oncology / Curr Opin Oncol. 2009 Mar;21(2):99-104. doi: 10.1097/CCO.0b013e328321049e.
2009
AOU San Luigi di Orbassano
Scagliotti GV; Longo M; Novello S;
Differential Thymidylate Synthase Expression in Different Variants of Large-Cell Carcinoma of the Lung. in Clinical cancer research : an official journal of the American Association for Cancer Research / Clin Cancer Res. 2009 Dec 15;15(24):7547-7552. doi: 10.1158/1078-0432.CCR-09-1641.
2009
AOU San Luigi di Orbassano
Monica V; Scagliotti GV; Ceppi P; Righi L; Cambieri A; Lo Iacono M; Saviozzi S; Volante M; Novello S; Papotti M;
The role of histology with common first-line regimens for advanced non-small cell lung cancer: a brief report of the retrospective analysis of a three-arm randomized trial. in Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer / J Thorac Oncol. 2009 Dec;4(12):1568-71. doi: 10.1097/JTO.0b013e3181c06980.
2009
AOU San Luigi di Orbassano
Scagliotti GV; De Marinis F; Rinaldi M; Crinò L; Gridelli C; Ricci S; Zhao YD; Liepa AM; Peterson P; Tonato M;
Excision repair cross complementing-1 and topoisomerase IIalpha gene expression in small-cell lung cancer patients treated with platinum and etoposide: a retrospective study. in Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer / J Thorac Oncol. 2008 Jun;3(6):583-9. doi: 10.1097/JTO.0b013e3181734f24.
2008
AOU San Luigi di Orbassano
Ceppi P; Longo M; Volante M; Novello S; Cappia S; Bacillo E; Selvaggi G; Saviozzi S; Calogero R; Papotti M; Scagliotti GV;
Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer. in Journal of clinical oncology : official journal of the American Society of Clinical Oncology / J Clin Oncol. 2008 Jul 20;26(21):3543-51. doi: 10.1200/JCO.2007.15.0375. Epub 2008 May 27.
2008
AOU San Luigi di Orbassano
Scagliotti GV; Parikh P; von Pawel J; Biesma B; Vansteenkiste J; Manegold C; Serwatowski P; Gatzemeier U; Digumarti R; Zukin M; Lee JS; Mellemgaard A; Park K; Patil S; Rolski J; Goksel T; de Marinis F; Simms L; Sugarman KP; Gandara D;
New data integrating multitargeted antifolates into treatment of first-line and relapsed non-small-cell lung cancer. in Clinical lung cancer / Clin Lung Cancer. 2008;9 Suppl 3:S122-8. doi: 10.3816/CLC.2008.s.018.
2008
AOU San Luigi di Orbassano
Scagliotti GV; Selvaggi G;
Basaloid adenocarcinoma. A new variant of pulmonary adenocarcinoma. in Virchows Archiv : an international journal of pathology / Virchows Arch. 2007 Sep;451(3):729-36. doi: 10.1007/s00428-007-0458-8. Epub 2007 Jul 6.
2007
AOU San Luigi di Orbassano
Marci V; Volante M; Cappia S; Righi L; Novello C; Scagliotti GV; Brambilla E; Papotti M;
Phase III study in stage IV non-small-cell lung cancer patients treated with two courses of cisplatin/gemcitabine followed by a randomization to three additional courses of the same combination or gemcitabine alone. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2007 May;18(5):903-8. doi: 10.1093/annonc/mdm061. Epub 2007 Mar 9.
2007
AOU San Luigi di Orbassano
Novello S; Bruzzi P; Barone C; Buosi R; Masotti A; Michetti G; Fioretti M; Barbera S; Spatafora M; Garetto L; Mazzanti P; Dongiovanni V; Selvaggi G; Crinò L; Scagliotti GV;
Emerging drugs for mesothelioma. in Expert opinion on emerging drugs / Expert Opin Emerg Drugs. 2007 Mar;12(1):127-37. doi: 10.1517/14728214.12.1.127.
2007
AOU San Luigi di Orbassano
Scagliotti GV; Selvaggi G;
Reactive thrombocytosis might contribute to chemotherapy-related thrombophilia in patients with lung cancer. in Clinical lung cancer / Clin Lung Cancer. 2007 Jan;8(4):264-7. doi: 10.3816/CLC.2007.n.004.
2007
AOU San Luigi di Orbassano
Zecchina G; Ghio P; Bosio S; Cravino M; Camaschella C; Scagliotti GV;
Neuro-endocrine tumours of the lung. A review of relevant pathological and molecular data. in Virchows Archiv : an international journal of pathology / Virchows Arch. 2007 Aug;451 Suppl 1:S51-9. doi: 10.1007/s00428-007-0445-0. Epub 2007 Aug 8.
2007
AOU San Luigi di Orbassano
Righi L; Volante M; Rapa I; Scagliotti GV; Papotti M;
Perspectives in adjuvant chemotherapy in NSCLC. in Expert review of respiratory medicine / Expert Rev Respir Med. 2007 Aug;1(1):99-110. doi: 10.1586/17476348.1.1.99.
2007
AOU San Luigi di Orbassano
Selvaggi G; Scagliotti GV;
Bone sialoprotein is predictive of bone metastases in resectable non-small-cell lung cancer: a retrospective case-control study. in Journal of clinical oncology : official journal of the American Society of Clinical Oncology / J Clin Oncol. 2006 Oct 20;24(30):4818-24. doi: 10.1200/JCO.2006.06.1952.
2006
AOU San Luigi di Orbassano
Papotti M; Kalebic T; Volante M; Chiusa L; Bacillo E; Cappia S; Lausi P; Novello S; Borasio P; Scagliotti GV;
Squamous cell carcinoma of the lung compared with other histotypes shows higher messenger RNA and protein levels for thymidylate synthase. in Cancer / Cancer. 2006 Oct 1;107(7):1589-96. doi: 10.1002/cncr.22208.
2006
AOU San Luigi di Orbassano
Ceppi P; Volante M; Saviozzi S; Rapa I; Novello S; Cambieri A; Lo Iacono M; Cappia S; Papotti M; Scagliotti GV;
Docetaxel-based induction therapy prior to radiotherapy with or without docetaxel for non-small-cell lung cancer. in British journal of cancer / Br J Cancer. 2006 May 22;94(10):1375-82. doi: 10.1038/sj.bjc.6603115.
2006
AOU San Luigi di Orbassano
Scagliotti GV; Szczesna A; Ramlau R; Cardenal F; Mattson K; Van Zandwijk N; Price A; Lebeau B; Debus J; Manegold C;
Prognostic role of protease-activated receptors 1 and 4 in resected stage IB non-small-cell lung cancer. in Clinical lung cancer / Clin Lung Cancer. 2006 May;7(6):395-400. doi: 10.3816/CLC.2006.n.023.
2006
AOU San Luigi di Orbassano
Ghio P; Cappia S; Selvaggi G; Novello S; Lausi P; Zecchina G; Papotti M; Borasio P; Scagliotti GV;
The way forward: new drugs and new therapeutic strategies in lung cancer therapy. in Clinical lung cancer / Clin Lung Cancer. 2006 May;7 Suppl 4:S109-10. doi: 10.3816/clc.2006.s.001.
2006
AOU San Luigi di Orbassano
Scagliotti GV; Novello S;
Cathepsin K is selectively expressed in the stroma of lung adenocarcinoma but not in bronchioloalveolar carcinoma. A useful marker of invasive growth. in American journal of clinical pathology / Am J Clin Pathol. 2006 Jun;125(6):847-54. doi: 10.1309/Q96A-YDAA-J3E1-TNWT.
2006
AOU San Luigi di Orbassano
Rapa I; Volante M; Cappia S; Rosas R; Scagliotti GV; Papotti M;
Antimetabolites and cancer: emerging data with a focus on antifolates. in Expert opinion on therapeutic patents / Expert Opin Ther Pat. 2006 Feb;16(2):189-200. doi: 10.1517/13543776.16.2.189.
2006
AOU San Luigi di Orbassano
Scagliotti GV; Selvaggi G;
A phase II study of paclitaxel in advanced bronchioloalveolar carcinoma (EORTC trial 08956). in Lung cancer (Amsterdam, Netherlands) / Lung Cancer. 2005 Oct;50(1):91-6. doi: 10.1016/j.lungcan.2005.05.012.
2005
AOU San Luigi di Orbassano
Scagliotti GV; Smit E; Bosquee L; O'Brien M; Ardizzoni A; Zatloukal P; Eberhardt W; Smid-Geirnaerdt M; de Bruin HG; Dussenne S; Legrand C; Giaccone G;
Three-year findings of an early lung cancer detection feasibility study with low-dose spiral computed tomography in heavy smokers. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2005 Oct;16(10):1662-6. doi: 10.1093/annonc/mdi314. Epub 2005 Jul 8.
2005
AOU San Luigi di Orbassano
Novello S; Fava C; Borasio P; Dogliotti L; Cortese G; Crida B; Selvaggi G; Lausi P; Brizzi MP; Sperone P; Cardinale L; Ferraris F; Perotto F; Priola A; Scagliotti GV;
Pemetrexed combined with oxaliplatin or carboplatin as first-line treatment in advanced non-small cell lung cancer: a multicenter, randomized, phase II trial. in Clinical cancer research : an official journal of the American Association for Cancer Research / Clin Cancer Res. 2005 Jan 15;11(2 Pt 1):690-6.
2005
AOU San Luigi di Orbassano
Scagliotti GV; Kortsik C; Dark GG; Price A; Manegold C; Rosell R; O'Brien M; Peterson PM; Castellano D; Selvaggi G; Novello S; Blatter J; Kayitalire L; Crino L; Paz-Ares L;
Management of bone metastases in cancer: a review. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2005 Dec;56(3):365-78. doi: 10.1016/j.critrevonc.2005.03.011. Epub 2005 Jun
2005
AOU San Luigi di Orbassano
Selvaggi G; Scagliotti GV;
State of the art in mesothelioma. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2005;16 Suppl 2:ii240-5. doi: 10.1093/annonc/mdi703.
2005
AOU San Luigi di Orbassano
Scagliotti GV; Novello S;
Pemetrexed in front-line chemotherapy for advanced non-small-cell lung cancer. in Oncology (Williston Park, N.Y.) / Oncology (Williston Park). 2004 Nov;18(13 Suppl 8):32-7.
2004
AOU San Luigi di Orbassano
Scagliotti GV; Novello S; Crino L; Rosell R;
Docetaxel in combined-modality treatment of inoperable locally or regionally advanced lung cancer. in Lung cancer (Amsterdam, Netherlands) / Lung Cancer. 2004 Dec;46 Suppl 2:S13-21. doi: 10.1016/s0169-5002(04)80037-0.
2004
AOU San Luigi di Orbassano
Scagliotti GV; Douillard JY;
Current development of adjuvant treatment of non-small-cell lung cancer. in Clinical lung cancer / Clin Lung Cancer. 2004 Dec;6 Suppl 2:S63-70. doi: 10.3816/clc.2004.s.016.
2004
AOU San Luigi di Orbassano
Scagliotti GV; Novello S;
Randomized study of adjuvant chemotherapy for completely resected stage I, II, or IIIA non-small-cell Lung cancer. in Journal of the National Cancer Institute / J Natl Cancer Inst. 2003 Oct 1;95(19):1453-61. doi: 10.1093/jnci/djg059.
2003
AOU San Luigi di Orbassano
Scagliotti GV; Fossati R; Torri V; Crinò L; Giaccone G; Silvano G; Martelli M; Clerici M; Cognetti F; Tonato M;
Pemetrexed and its emerging role in the treatment of thoracic malignancies. in Expert opinion on investigational drugs / Expert Opin Investig Drugs. 2003 May;12(5):853-63. doi: 10.1517/13543784.12.5.853.
2003
AOU San Luigi di Orbassano
Scagliotti GV; Novello S;
Adjuvant therapy in completely resected non-small-cell lung cancer. in Current oncology reports / Curr Oncol Rep. 2003 Jul;5(4):318-25. doi: 10.1007/s11912-003-0074-y.
2003
AOU San Luigi di Orbassano
Scagliotti GV; Novello S;
Efficacy of neoadjuvant strategies with gemcitabine and other chemotherapy in resectable non-small cell lung cancer: a combined modality approach. in Seminars in oncology / Semin Oncol. 2003 Aug;30(4 Suppl 10):13-8. doi: 10.1016/s0093-7754(03)00280-x.
2003
AOU San Luigi di Orbassano
Scagliotti GV; Novello S;
Phase II study of pemetrexed with and without folic acid and vitamin B12 as front-line therapy in malignant pleural mesothelioma. in Journal of clinical oncology : official journal of the American Society of Clinical Oncology / J Clin Oncol. 2003 Apr 15;21(8):1556-61. doi: 10.1200/JCO.2003.06.122.
2003
AOU San Luigi di Orbassano
Scagliotti GV; Shin DM; Kindler HL; Vasconcelles MJ; Keppler U; Manegold C; Burris H; Gatzemeier U; Blatter J; Symanowski JT; Rusthoven JJ;
Gemcitabine (Gemzar)-based induction chemotherapy in non-small-cell lung cancer. in Lung cancer (Amsterdam, Netherlands) / Lung Cancer. 2002 Nov;38 Suppl 2:S13-9. doi: 10.1016/s0169-5002(02)00352-5.
2002
AOU San Luigi di Orbassano
Scagliotti GV; Novello S;
HER-2/neu overexpression in patients with radically resected nonsmall cell lung carcinoma. Impact on long-term survival. in Cancer / Cancer. 2002 May 15;94(10):2669-74. doi: 10.1002/cncr.10531.
2002
AOU San Luigi di Orbassano
Selvaggi G; Scagliotti GV; Torri V; Novello S; Leonardo E; Cappia S; Mossetti C; Ardissone F; Lausi P; Borasio P;
Tyrosine kinase signal transduction inhibitors. Clinical trials. in I supplementi di Tumori : official journal of Societa italiana di cancerologia ... [et al.] / Suppl Tumori. 2002 Jul-Aug;1(4):S34-6.
2002
AOU San Luigi di Orbassano
Scagliotti GV;
Phase II study of high-dose paclitaxel and carboplatin in previously untreated, unresectable non-small cell lung cancer. in Lung cancer (Amsterdam, Netherlands) / Lung Cancer. 2001 Nov;34(2):261-9. doi: 10.1016/s0169-5002(01)00238-0.
2001
AOU San Luigi di Orbassano
Novello S; Galli L; Antonuzzo A; Crinó L; Pozzi E; Selvaggi G; Ricci S; Marrocolo F; Darwish S; Sorbolini S; Tonato M; Scagliotti GV;
Role of erythropoietin in the treatment of lung cancer associated anaemia. in Lung cancer (Amsterdam, Netherlands) / Lung Cancer. 2001 Dec;34 Suppl 4:S91-4. doi: 10.1016/s0169-5002(01)00398-1.
2001
AOU San Luigi di Orbassano
Scagliotti GV; Novello S;
Phase I/II dose finding study of paclitaxel and carboplatin in advanced non-small cell lung cancer. in Lung cancer (Amsterdam, Netherlands) / Lung Cancer. 1999 Jul;25(1):39-46. doi: 10.1016/s0169-5002(99)00048-3.
1999
AOU San Luigi di Orbassano
Scagliotti GV; Crinó L; Pozzi E; Corgna E; Selvaggi G; Novello S; Salsano G; Gentile A; Palladino M; Marracolo F; Tonato M;
Multidrug resistance in non-small-cell lung cancer. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 1999;10 Suppl 5:S83-6. doi: 10.1093/annonc/10.suppl_5.s83.
1999
AOU San Luigi di Orbassano
Scagliotti GV; Novello S; Selvaggi G;
Chemotherapy of non-small cell lung cancer. in Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace / Monaldi Arch Chest Dis. 1997 Jun;52(3):287-95.
1997
AOU San Luigi di Orbassano
Scagliotti GV; Crinò L;
Neo-adjuvant chemotherapy prior to surgery in stage III non-small cell lung cancer. in Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace / Monaldi Arch Chest Dis. 1997 Dec;52(6):531-4.
1997
AOU San Luigi di Orbassano
Scagliotti GV; Ferrari G; Novello S;
Phase II study of intensive chemotherapy with carboplatin, ifosfamide and etoposide plus recombinant human granulocyte colony-stimulating factor and sequential radiotherapy in locally advanced, unresectable non-small-cell lung cancer. in Cancer chemotherapy and pharmacology / Cancer Chemother Pharmacol. 1996;38(6):561-5. doi: 10.1007/s002800050527.
1996
AOU San Luigi di Orbassano
Scagliotti GV; Ricardi U; Crinó L; Maranzano E; De Marinis F; Morandi MG; Meacci L; Marangolo M; Emiliani E; Rosti G; Figoli F; Bolzicco G; Masiero P; Gentile A; Tonato M;
Biological prognostic factors in non-small cell lung cancer. in Lung cancer (Amsterdam, Netherlands) / Lung Cancer. 1995 Apr;12 Suppl 1:S13-25. doi: 10.1016/0169-5002(95)00417-y.
1995
AOU San Luigi di Orbassano
Scagliotti GV; Masiero P; Pozzi E;
Immunohistochemical evaluation of P-glycoprotein in human malignancies by monoclonal antibody MC57. in International journal of cancer / Int J Cancer. 1994 Jun 15;57(6):841-6. doi: 10.1002/ijc.2910570613.
1994
AOU San Luigi di Orbassano
Leonardo E; Valente G; Cappia S; Cianfriglia M; Arancia G; Meschini S; Scagliotti GV;
Chronic administration of lonidamine in untreated non-small cell lung cancer of stage III M0-1. in Chemotherapy / Chemotherapy. 1989;35(1):64-8. doi: 10.1159/000238637.
1989
AOU San Luigi di Orbassano
Scagliotti GV; Gozzelino F; Albera C; Pescetti G;